Andrew Favor

I am a bioinformatics advisor for Nextbiotics, a biotechnology company that utilizes synthetic biology approaches to provide solutions to the emergence of antibiotic-resistant bacteria. My research focuses on protein design, machine learning, and the use of computational tools to develop new types of materials and medicines. In my previous research experience, in academia and industry, I focused on utilizing modified bacteriophage proteins to create drug-delivery vehicles and antimicrobial agents. I hold a B.S. in Chemical Biology and M.S. in Materials Science and Engineering from the University of California, Berkeley, and am currently a Molecular Engineering PhD student at the University of Washington.